Company Dossier · Consumer Staples
Clorox
- S&P 500
- Russell 1000
What Clorox is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to March 31, 2026: $6.76 billion, down 3.7% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to March 31, 2026: $0.38 billion, down 53% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to March 31, 2026: $0.20 billion, down 13% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to June 30, 2025: $0.33 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (August 3, 2026): sentiment -0.20 on a −1 to +1 scale (negative), confidence 0.60 of 1.Palanor Discourse
- Latest annual report (filed August 7, 2026): 0 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net buyers in Q2 2026: $0.4 million on the open market.SEC Form 4
- 1,057 institutional managers reported a position at June 30, 2026 (−33 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 4 (1 a year earlier).U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →What Clorox is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Expanding ↔ Retrenching
Withheld: 50% of the evidence is readable at this date (needs 60%).
- Capital spending—
- Debt raised—
- Buybacks vs capex—
- Hiring filings8th pct
- Deals and private raises49th pct
- Patent publications76th pct
Confident ↔ Hedging
Hedging
- Call sentiment19th pct
- Call confidence47th pct
- Guidance changes41st pct
- Risk factors added—
- Insider open-market trades89th pct
- − Call sentiment
- + Insider open-market trades
- − Guidance changes
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver37th pct
- Stress filings48th pct
Credit
How these are built →Clorox's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$4.1B
- Due within a year $1.6B
- Longer term $2.5B
- Default point $2.8B (short + ½ long)
Finance leases included · Mar 31, 2026 filing
Bonds priced, last 12 months
$1.5B
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
| Priced | Amount | Coupon | Matures | Spread | Yield |
|---|---|---|---|---|---|
| May 6, 2026 | $550M | 5.250% | 2036 (10y) | +90bp | 5.250% |
| May 6, 2026 | $550M | 4.700% | 2031 (5y) | +70bp | 4.701% |
| May 6, 2026 | $400M | 4.950% | 2033 (7y) | +80bp | 4.976% |
From the pricing term sheets Clorox filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Clorox, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralClorox Has Some Great Brands. Is its Stock a Good Value?
insidermonkey.com · via Marketaux · Oct 3, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 15, 2026LobbyingLobbying report (CURRENT STRATEGIES)third_quarter 2026 · $0.2 million
- Oct 13, 2026Patent
- Oct 6, 2026Patent
- Sep 15, 2026Trademark
- Sep 1, 2026Patent
- Aug 25, 2026Patent
- Aug 25, 2026Patent
- Aug 7, 202610-K
- Jul 20, 2026LobbyingLobbying report (CURRENT STRATEGIES)second_quarter 2026 · $0.2 million
- Jul 8, 2026Trademark
- Jul 8, 2026Trademark
- Jun 22, 2026Trademark
- Jun 17, 20268-KDirector or officer changeItem 5.02
- May 28, 20268-KDirector or officer changeItem 5.02
- Apr 20, 2026LobbyingLobbying report (CURRENT STRATEGIES)first_quarter 2026 · $0.1 million
- Apr 13, 2026Trademark
- Mar 10, 20268-KMaterial agreement signedItem 1.01
- Jan 21, 2026LobbyingLobbying report (CURRENT STRATEGIES)fourth_quarter 2025 · $0.1 million
- Jan 21, 2026LobbyingLobbying report (CURRENT STRATEGIES)fourth_quarter 2025 · $0.1 million
- Jan 16, 2026LobbyingLobbying report (BANNER PUBLIC AFFAIRS, LLC)fourth_quarter 2025
- Nov 20, 20258-KShareholder vote resultsItem 5.07
- Nov 12, 2025LobbyingLobbying report (CURRENT STRATEGIES)fourth_quarter 2025
- Oct 30, 20258-KDirector or officer changeItem 5.02
- Oct 20, 2025LobbyingLobbying report (BANNER PUBLIC AFFAIRS, LLC)third_quarter 2025 · $0.1 million
- Aug 8, 202510-K
- May 12, 20258-KDirector or officer changeItem 5.02
- Mar 28, 20258-KMaterial agreement signedItem 1.01
- Mar 28, 20258-KMaterial agreement terminatedItem 1.02
- Jan 28, 20258-KDirector or officer changeItem 5.02
- Nov 21, 20248-KShareholder vote resultsItem 5.07
- Aug 8, 202410-K
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Church & Dwight CHD | $6.2B | — | Jun 30, 2026 |
| Kimberly-Clark KMB | $16.6B | $1.8B | Jun 30, 2026 |
| Colgate-Palmolive CL | $21.1B | $3.9B | Jun 30, 2026 |
| Procter & Gamble PG | $87.0B | $15.2B | Jun 30, 2026 |
| Primo Brands PRMB | $6.7B | $0.4B | Jun 30, 2026 |
| Lamb Weston LW | $6.6B | $0.4B | Aug 30, 2026 |
| Darling Ingredients DAR | $6.5B | — | Jul 4, 2026 |
| Ingredion INGR | $7.2B | $0.4B | Jun 30, 2026 |